High PD-L1 expression associates with low T-cadherin expression and poor prognosis in human papillomavirus-negative head and neck squamous cell carcinoma

被引:4
|
作者
Wang, Qiuju [1 ]
Zhao, Yanzhen [2 ]
Chen, Yan [1 ]
Chen, Yibo [1 ]
Song, Xiaoyu [1 ]
Zhang, Li [1 ]
He, Qiao [1 ]
Ye, Bo [1 ]
Wu, Lichun [1 ]
Huang, Xinyue [1 ]
Wang, Dongsheng [1 ,3 ]
机构
[1] Univ Elect Sci & Technol China, Sichuan Canc Hosp & Inst, Sichuan Canc Ctr, Sch Med, Chengdu, Peoples R China
[2] Third Affiliated Hosp Guangzhou Med Univ, Guangzhou, Peoples R China
[3] Sichuan Canc Hosp & Inst, 55 South Renmin Rd,Wuhou Dist, Chengdu, Peoples R China
关键词
HNSCC; HPV-negative; PD-L1; prognosis; T-cadherin; OPEN-LABEL; CANCER; TUMOR; PEMBROLIZUMAB; METHYLATION; IMPACT; SERUM; PROLIFERATION; CHEMOTHERAPY; MULTICENTER;
D O I
10.1002/hed.27329
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
BackgroundThis study aimed at exploring the correlation between T-cadherin and programmed death-ligand 1 (PD-L1), as well as their prognostic value in patients with human papillomavirus (HPV)-negative head and neck squamous cell carcinoma (HNSCC). MethodsImmunohistochemical staining was used to identify the protein expression of T-cadherin and PD-L1. Spearman linear correlation analysis was used to determine their association. Kaplan-Meier analysis was utilized to plot overall survival (OS) and disease-free survival (DFS) curves. Cox proportional hazards regression was used to conduct univariate and multivariate analysis. ResultsThe results showed a negative association between protein expression of T-cadherin and PD-L1 (r = -0.760, p < 0.001), positive expression of T-cadherin was associated with a better OS (p < 0.001) and DFS (p < 0.001), while positive PD-L1 expression was associated with a worse OS (p = 0.002) and DFS (p < 0.001). The expression of T-cadherin and PD-L1 were independent prognostic predictors for OS and DFS. ConclusionsIn conclusion, expression of T-cadherin and PD-L1 were largely inversely correlated and independent prognostic factors for patients with HPV-negative HNSCC.
引用
收藏
页码:1162 / 1171
页数:10
相关论文
共 50 条
  • [1] PD-L1 expression in recurrent head and neck squamous cell carcinoma
    Delafoy, Alice
    Uguen, Arnaud
    Lemasson, Gilles
    Conan-Charlet, Virginie
    Pradier, Olivier
    Lucia, Francois
    Schick, Ulrike
    [J]. EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2022, 279 (01) : 343 - 351
  • [2] PD-L1 expression in recurrent head and neck squamous cell carcinoma
    Delafoy, A.
    Uguen, A.
    Key, S.
    Lucia, F.
    Lemasson, G.
    Abgral, R.
    Dissaux, G.
    Pradier, O.
    Schick, U.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S627 - S628
  • [3] PD-L1 expression in recurrent head and neck squamous cell carcinoma
    Alice Delafoy
    Arnaud Uguen
    Gilles Lemasson
    Virginie Conan-Charlet
    Olivier Pradier
    François Lucia
    Ulrike Schick
    [J]. European Archives of Oto-Rhino-Laryngology, 2022, 279 : 343 - 351
  • [4] Evofosfamide for the treatment of human papillomavirus-negative head and neck squamous cell carcinoma
    Jamieson, Stephen M. F.
    Tsai, Peter
    Kondratyev, Maria K.
    Budhani, Pratha
    Liu, Arthur
    Senzer, Neil N.
    Chiorean, E. Gabriela
    Jalal, Shadia I.
    Nemunaitis, John J.
    Kee, Dennis
    Shome, Avik
    Wong, Way W.
    Li, Dan
    Poonawala-Lohani, Nooriyah
    Kakadia, Purvi M.
    Knowlton, Nicholas S.
    Lynch, Courtney R. H.
    Hong, Cho R.
    Lee, Tet Woo
    Grenman, Reidar A.
    Caporiccio, Laura
    McKee, Trevor D.
    Zaidi, Mark
    Butt, Sehrish
    Macann, Andrew M. J.
    McIvor, Nicholas P.
    Chaplin, John M.
    Hicks, Kevin O.
    Bohlander, Stefan K.
    Wouters, Bradly G.
    Hart, Charles P.
    Print, Cristin G.
    Wilson, William R.
    Curran, Michael A.
    Hunter, Francis W.
    [J]. JCI INSIGHT, 2018, 3 (16):
  • [5] Expression profile and in vitro blockade of programmed death-1 in human papillomavirus-negative head and neck squamous cell carcinoma
    Malm, Ian-James
    Bruno, Tullia C.
    Fu, Juan
    Zeng, Qi
    Taube, Janis M.
    Westra, William
    Pardoll, Drew
    Drake, Charles G.
    Kim, Young J.
    [J]. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2015, 37 (08): : 1088 - 1095
  • [6] High PD-L1 Expression Correlates with Metastasis and Poor Prognosis in Oral Squamous Cell Carcinoma
    Lin, Yueh-Min
    Sung, Wen-Wei
    Hsieh, Ming-Ju
    Tsai, Shih-Chen
    Lai, Hung-Wen
    Yang, Shu-Mei
    Shen, Ko-Hong
    Chen, Mu-Kuan
    Lee, Huei
    Yeh, Kun-Tu
    Chen, Chih-Jung
    [J]. PLOS ONE, 2015, 10 (11):
  • [7] Intratumor heterogeneity of PD-L1 expression in head and neck squamous cell carcinoma
    Jacob H. Rasmussen
    Giedrius Lelkaitis
    Katrin Håkansson
    Ivan R. Vogelius
    Helle H. Johannesen
    Barbara M. Fischer
    Søren M. Bentzen
    Lena Specht
    Claus A. Kristensen
    Christian von Buchwald
    Irene Wessel
    Jeppe Friborg
    [J]. British Journal of Cancer, 2019, 120 : 1003 - 1006
  • [8] Intratumor heterogeneity of PD-L1 expression in head and neck squamous cell carcinoma
    Rasmussen, Jacob H.
    Lelkaitis, Giedrius
    Hakansson, Katrin
    Vogelius, Ivan R.
    Johannesen, Helle H.
    Fischer, Barbara M.
    Bentzen, Soren M.
    Specht, Lena
    Kristensen, Claus A.
    von Buchwald, Christian
    Wessel, Irene
    Friborg, Jeppe
    [J]. BRITISH JOURNAL OF CANCER, 2019, 120 (10) : 1003 - 1006
  • [9] Expression level of PD-L1 is involved in ALDH1A1-mediated poor prognosis in patients with head and neck squamous cell carcinoma
    Zhou, Li
    Wang, Xuezhou
    Yu, Wenwen
    Yang, Lili
    Wei, Feng
    Sun, Qian
    Wang, Yang
    Kou, Fan
    Dong, Ruifeng
    Ren, Xiubao
    Zhang, Xinwei
    [J]. PATHOLOGY RESEARCH AND PRACTICE, 2020, 216 (09)
  • [10] High-Grade Neuroendocrine Carcinoma of the Head and Neck: Human Papillomavirus Status and PD-L1 Expression
    Bahr, Katharina
    Zimmer, Stefanie
    Springer, Erik
    Fottner, Christian
    Becker, Sven
    Ernst, Benjamin P.
    Matthias, Christoph
    Kuenzel, Julian
    [J]. ORL-JOURNAL FOR OTO-RHINO-LARYNGOLOGY HEAD AND NECK SURGERY, 2019, 81 (5-6): : 309 - 316